Hidetaka Hiramatsu

Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)

Takamichi Yamamoto, Sung Chul Lim, Hirotomo Ninomiya et al. · Epilepsia Open · 2020 · 44 citations · Full text

Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal‐onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open‐label Study 342 (FREEDOM)

Ryan Edbert Husni, Leock Y. Ngo, Hirofumi Senokuchi et al. · Epilepsia Open · 2021 · 21 citations · Full text

Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese patients with epilepsy

Naotaka Usui, Naoki Akamatsu, Nobukazu Nakasato et al. · Seizure · 2018 · 18 citations